Judge orders Trump administration to deliver full SNAP benefits to states by Friday

In West Virginia, coal miners suffering from black lung disease are standing up against the Trump administration's rollback of crucial safety protections. This fight is significant as it highlights the ongoing struggles of miners who have long battled for their rights and health in an industry fraught with danger. The legacy of these workers is not just about the coal they extract, but also about the protections they have fought hard to secure for themselves and future generations.

Eli Lilly's CEO, David Ricks, recently discussed a new agreement with the Trump administration aimed at reducing the prices of their weight loss drug, Zepbound. This deal is significant as it reflects a growing trend towards making essential medications more affordable for consumers, potentially improving access to treatment for many individuals struggling with weight management.

SNAP recipients are facing a dire situation as delays in November payments leave many without food. A judge has intervened, ordering the Trump administration to ensure that benefits are distributed by Friday. This delay is critical because it affects the most vulnerable populations who rely on these benefits for their daily sustenance, highlighting the urgent need for timely assistance.

A federal judge in Rhode Island has ordered the Trump administration to ensure full funding for SNAP benefits in November, a crucial decision for many families relying on this support. This ruling highlights the ongoing legal battles over social welfare programs and their funding, emphasizing the importance of food assistance during challenging times.

The Trump administration is on the verge of finalizing a deal with two major drug companies to significantly lower the prices of weight-loss medications. This agreement could bring the cost of the lowest doses of Zepbound and Wegovy down to as low as $149 a month, making these treatments more accessible to those struggling with weight management. This is important as it could lead to improved health outcomes for many individuals who need these medications but have been deterred by high costs.